Trials / Unknown
UnknownNCT05772338
Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous Stomatitis
National, Multicenter, Randomized, Double-blind, Pilot Study to Evaluate the Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous Stomatitis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 102 (estimated)
- Sponsor
- EMS · Industry
- Sex
- Female
- Age
- 12 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of BNP105 in the treatment of recurrent aphthous stomatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BNP105 (25 + 25 + 15) | BNP105 oral suspension, 25 mg + 25 mg + 15 mg, oral. Up to six applications per day. |
| OTHER | Placebo | Placebo. Up to six applications per day. |
Timeline
- Start date
- 2024-01-22
- Primary completion
- 2025-01-01
- Completion
- 2025-04-01
- First posted
- 2023-03-16
- Last updated
- 2024-02-20
Locations
2 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05772338. Inclusion in this directory is not an endorsement.